For now, there is no definitive test for Alzheimer’s disease. Doctors rely on cognition tests and brain scans. So one of the main goals of Alzheimer’s research is to find ways of detecting the disease earlier.
A new technique published in the journal Genome Biology showed differences in the tiny fragments of genetic material floating in the blood could be used to identify the disease in patients. Early trials showed that the test was successfully “able to distinguish with high diagnostic accuracies between Alzheimer’s disease patients and healthy” people.
Read the full, original story here: Alzheimer’s blood test edges closer
